NORTH CHICAGO, Ill., April 21, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Deutsche Bank 42ndAnnual Health Care Conference on Wednesday, May 3, 2017. William Chase, executive vice president and chief financial officer, will present at 7:40 a.m. Central time.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs approximately 29,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300443332.html
Subscribe to our Free Newsletters!